Description
Dedication… About the Editor… Series Preface… Preface… Table of Contents… Contributing Authors… Part I. Recent Progress in Understanding Molecular Etiology of Alzheimer’s Disease 1. Recent Progress in the Treatment Strategies of Alzheimer’s Disease Vinay Kumar and Kunal Roy Part II. Recent Advances in Computational Modeling of Anti-Alzheimer Drugs 2. Understanding the Mechanisms of Amyloid Beta (A) Aggregation by Computational Modeling Praveen P. N. Rao, Yusheng Zhao, and Rui Huang 3. Recent Advances in Computational Modeling of BACE1 Inhibitors as Anti-Alzheimer Agents Konstantinos D. Papavasileiou, Francesco Dondero, Georgia Melagraki, and Antreas Afantitis 4. Modeling of BACE-1 Inhibitors as Anti-Alzheimer’s Agents Thamires Quadros Froes, Deyse Brito Barbosa, Mayra Ramos do Bomfim, Franco Henrique Andrade Leite, and Marcelo Santos Castilho 5. Computational Modeling of Kinase Inhibitors as Anti-Alzheimer Agents Priyanka De and Kunal Roy 6. Computer-Assisted Drug Design: A Toolbox for Novel Tau Kinase Inhibitors and Its Implications in Alzheimer’s Disease Arvind Kumar Jain, C. Karthikeyan, Piyush Trivedi, and Anita Dutt Konar 7. Computational Modeling Approaches in Search of Anti-Alzheimer Agents: Case Studies of Phosphodiesterase Inhibitors Vinay Kumar and Kunal Roy 8. Recent Advances in Computational Modeling of Multi-Targeting Inhibitors as Anti-Alzheimer Agents Khac-Minh Thai, Thai-Son Tran, The-Huan Tran, Thi-Cam-Nhung Cao, Hoang-Nhan Ho, Phuong Nguyen Hoai Huynh, Tan Thanh Mai, Thanh-Dao Tran, Minh-Tri Le, and Van-Thanh Tran 9. Computational Modeling of PET and SPECT Imaging Agents as Diagnostics for Alzheimer’s Disease Priyanka De and Kunal Roy Part III Computational Modeling of Anti-Alzheimer Drugs Against Newer Targets 10. Computational Modeling of DYRK1A Inhibitors as Potential Anti-Alzheimer Agents Eva Serrano-Candelas, Laureano E. Carpio, and Rafael Gozalbes 11. Computational Modeling of MAO Inhibitors as Anti-Alzheimer Agents Gurmeet Kaur, Deepti Goyal, and Bhupesh Goyal 12. Computational Modeling of Phosphodiesterase Inhibitors as Anti-Alzheimer Agents Ioanna-Chrysoula Tsopka and Dimitra Hadjipavlou-Litina 13. Computational Methods for the Design and Development of Glutaminyl Cyclase Inhibitors in Alzheimer’s Disease Kiran Bagri, Ashwani Kumar, Parvin Kumar, Archana Kapoor, and Vikas Verma Part IV Special Topics 14. Basic Information Science Methods for Insight into Neurodegenerative Pathogenesis Thomas H.W. Lushington, Mary I. Zgurzynski, and Gerald H. Lushington 15. Network Pharmacology for Drug Repositioning in Anti-Alzheimer’s Drug Development Raju Dash, Yeasmin Akter Munni, Sarmistha Mitra, Nayan Dash, and Il Soo Moon 16. Web Services for the Prediction of ADMET Parameters Relevant to the Design of Neuroprotective Drugs Valentin O. Perkin, Grigory V. Antonyan, Eugene V. Radchenko, and Vladimir A. Palyulin Subject Index List…
